Glibenclamide (Daonil - Hoechst; Euglucon - Roussel) is claimed to be the most active and least toxic antidiabetic agent so far produced. Like other hypoglycaemic sulphonylureas it lowers the blood sugar at least in part by stimulating the release of endogenous insulin1 and is suitable for the treatment of maturity-onset diabetes.
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.